| A7 | Daily immunological and virological variations in aviremic ART-treated people living with HIV | E-poster | Cellular immunity |
| B64 | Daily ferrous sulfate supplementation for three months improved iron status in South African schoolchildren living with HIV | E-poster | HIV complications and co-morbidities in paediatric and adolescent populations |
| D55 | Cyclical engagement in HIV care: a qualitative study of clinic transfers to re-enter HIV care in Cape Town, South Africa | E-poster | Qualitative and ethnographic methods in HIV research |
| D10 | CUSTOMIZE: overall results from a hybrid III implementation-effectiveness study examining implementation of cabotegravir and rilpivirine long-acting injectable for HIV treatment in US healthcare settings; final patient and provider data | On-demand oral abstract session | Operational challenges in implementing HIV services |
| D50 | Custom indicator reporting to improve PEPFAR key population data quality | E-poster | Monitoring and evaluation of HIV cascade |
| B20 | Cumulative viral load on antiretroviral therapy and breast cancer risk among women with HIV in North America | E-poster | Malignancies (AIDS and non-AIDS related) |
| A7 | Cross-reactivity to mutated viral immune targets can influence CD8+ T cell functionality: an alternative viral adaptation strategy | E-poster | Cellular immunity |
| D55 | Critical hope as a research method in HIV research: lessons learned from multi-method qualitative research with transgender women of colour | E-poster | Qualitative and ethnographic methods in HIV research |
| D68 | COVID-19 vaccine hesitancy and associated factors among people with HIV in the United States: findings from a national survey | E-poster | Living with HIV and co-infections and/or co-morbidities |
| D71 | COVID-19 related stressors and HIV status neutral care among black men who have sex with men and black transgender women in the U.S. during COVID-19 pandemic | E-poster | Conceptualizing social and structural factors and their impacts |